Sydän- ja verisuonitautien paino
Sydän- ja verisuonitautien paino: tuleva pilottitutkimus liikalihavista aikuisista, joilla on sydän- ja verisuonisairauksia, arvioitu uudessa kardiometabolisessa klinikassa
The purpose of this study is to evaluate the impact of a cardiometabolic clinic on percent body weight loss, body mass index (BMI), and visceral adiposity distribution in obese adults with cardiovascular disease (CVD) at 12 months.
Tutkimuksen yleiskatsaus
Tila
Tila
Ehdot
Ehdot
Opintotyyppi
Opintotyyppi
Ilmoittautuminen (Todellinen)
Ilmoittautuminen
Yhteystiedot ja paikat
Opiskelupaikat
-
-
Minnesota
-
Rochester, Minnesota, Yhdysvallat, 55905
- Mayo Clinic in Rochester
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Näytteenottomenetelmä
Tutkimusväestö
Patients referred to the cardiometabolic clinic at Mayo Clinic Hospital in Rochester, MN will be recruited for participation.
Kuvaus
Inclusion Criteria:
- BMI ≥30 kg/m2
- At least one of the following CVD: atrial fibrillation (AF), coronary artery disease (CAD), HFpEF (heart failure with preserved ejection fraction), HFrEF (heart failure with reduced ejection fraction), ACHD (adult congenital heart disease), or valvular heart disease
- Patients evaluated in the Cardiometabolic clinic
- Willingness to complete questionnaires/surveys
- Ability to complete monthly self-assessments at home
Exclusion Criteria:
- BMI <30 kg/m2
- Pregnancy or lactating women
- Hemodynamically unstable CVD
- Active malignancy
- Autoimmune or systemic inflammatory diseases
- Severe renal or hepatic failure
- Being considered unsafe to participate as determined by the study physician
- Taking medications affecting weight or energy intake/energy expenditure in the last 6 months, including weight loss medications, antipsychotic medications, or other medications as determined by the study NP or physician
- Patients with active psychosis, mania, or substance use disorders
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Havaintomallit: COHORT
- Aikanäkymät: PROSPECTIVE
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Percent body weight loss
Aikaikkuna: 12 months
|
Total percent body weight loss will be reported at 12 months based on the following formula: (Starting baseline weight minus current weight) / (starting baseline weight) x 100 equals % of body weight loss. |
12 months
|
|
Change in Body Mass Index (BMI)
Aikaikkuna: Baseline, 12 months
|
Body Mass Index (BMI) will be calculated using the standard formula from participants' height and weight. BMI = (Weight in Pounds / (Height in inches x Height in inches)) x 703 |
Baseline, 12 months
|
|
Change in visceral adiposity distribution
Aikaikkuna: Baseline, 12 months
|
Change in visceral adiposity distribution measured using dual energy X-ray absorptiometry (DEXA). |
Baseline, 12 months
|
Toissijaiset tulostoimenpiteet
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Change in Blood Pressure
Aikaikkuna: Baseline, 12 months
|
Measured in millimeters of mercury (mmHg) |
Baseline, 12 months
|
|
Change in point of care glucose
Aikaikkuna: Baseline, 12 months
|
Change in estimated glucose value (mg/dl) obtained from point of care fingerstick testing. |
Baseline, 12 months
|
|
Change in quality of diet
Aikaikkuna: Baseline, 12 months
|
Change in quality of diet will be assessed by the Mini-EAT (Eating Assessment Tool). The Mini-EAT is a 9 item questionnaire that asks subjects how often they eat different types of foods (e.g. fruits, vegetables, legumes, etc.). Subjects respond on a scale of "I do not eat it at all" to "6 or more servings per day." Higher scores on the Mini-EAT represent a better quality of diet. |
Baseline, 12 months
|
|
Change in psychosocial distress as measured by Screening Tool for Psychological Distress (STOP-D)
Aikaikkuna: Baseline, 12 months
|
Psychosocial distress will be measured by the STOP-D survey. The STOP-D survey asks subjects to rate how often over the last 2 weeks they have felt depressed, anxious, stressed, angry, or lacking social support on a scale of 0-Not at all to 9-Severely. Each item is scored separately without a summed score for overall distress. Higher individual scores on the STOP-D items represent worse psychosocial distress. |
Baseline, 12 months
|
|
Change in psychosocial distress as measured by Impact of Event Scale-Revised (IES-R)
Aikaikkuna: Baseline, 12 months
|
Psychosocial distress will be measured by the IES-R. The IES-R is a questionnaire which asks subjects to rate how distressed or bothered during the past seven days they have been by difficulties that people sometimes have after stressful life events. Responses can range from 0-Not at all to 4-Extremely. Items on the questionnaire are grouped into 3 subscales: Intrusion, Avoidance, and Hyperarousal with scores on each subscale being the mean item response of all items in that group, thus scores for each subscale also range from 0 to 4. Higher scores are indicative of more psychosocial distress following the specific life event of focus. |
Baseline, 12 months
|
|
Change in psychosocial distress as measured by Adverse Childhood Experience (ACE) Questionnaire
Aikaikkuna: Baseline, 12 months
|
Psychosocial distress will be measured by the ACE Questionnaire. The ACE Questionnaire asks subjects various questions regarding life experiences from the first 18 years of life that may be considered adverse experiences (e.g. parental abuse, neglect, parental divorce, etc.). Subjects answer each question with a yes or no selection. The more questions answered yes represents worse psychosocial distress. |
Baseline, 12 months
|
|
Change in functional aerobic capacity (VO2 Max)
Aikaikkuna: Baseline, 12 months
|
VO2 Max is measured as milliliters of oxygen per kilogram of body weight per minute (ml/kg/min) during cardiopulmonary exercise test |
Baseline, 12 months
|
|
Change in artificial intelligence electrocardiogram (AI-ECG) age
Aikaikkuna: Baseline, 12 months
|
AI-ECG age is the subject's predicted age based on artificial intelligence analysis of electrocardiograms (ECGs). |
Baseline, 12 months
|
|
Change in E/e'
Aikaikkuna: Baseline, 12 months
|
E/e' will be measured using transthoracic echocardiography (TTE). It is defined as the ratio of peak early diastolic mitral inflow velocity (E) and peak early diastolic mitral annular velocity (e') and will be used to assess left ventricular diastolic function. |
Baseline, 12 months
|
|
Change in Peak Tricuspid Regurgitation (TR) Velocity
Aikaikkuna: Baseline, 12 months
|
Peak TR Velocity (m/s) will be measured using transthoracic echocardiography (TTE) to assess left ventricular diastolic function. |
Baseline, 12 months
|
|
Change in Right Atrial (RA) Pressure
Aikaikkuna: Baseline, 12 months
|
RA pressure (mm Hg) will be measured by transthoracic echocardiography (TTE) to assess left ventricular diastolic function. |
Baseline, 12 months
|
|
Change in Left Atrial (LA) volume index
Aikaikkuna: Baseline, 12 months
|
LA volume index (ml/m^2) will be measured by transthoracic echocardiography (TTE) to assess left ventricular diastolic function. |
Baseline, 12 months
|
|
Change in physical activity
Aikaikkuna: Baseline, 12 months
|
Average number of steps a subject takes daily as collected by an Apple watch worn by subjects for the duration of the study. |
Baseline, 12 months
|
|
Change in heart rate with detection of arrhythmia
Aikaikkuna: Baseline, 12 months
|
Average number of arrhythmias identified by an Apple watch worn by subjects for the duration of the study. |
Baseline, 12 months
|
|
Change in cardio fitness
Aikaikkuna: Baseline, 12 months
|
Fitness level reported as high/above average/below average/low as collected by an Apple watch worn by subjects for the duration of the study. |
Baseline, 12 months
|
|
Change in six-minute walk test
Aikaikkuna: Baseline, 12 months
|
Measurement (meters) of distance a person can walk on flat ground in 6 minutes collected by an Apple watch worn by subjects for the duration of the study. |
Baseline, 12 months
|
|
Change in psychosocial distress as measured by the Weight Bias Internalization-Modified (WBIS-M) scale
Aikaikkuna: Baseline, 12 months
|
The WBIS-M is a 11-item instrument for measuring the extent to which overweight individuals think of themselves in terms of prevalent negative stereotypes about overweight and overweight individuals. Respondents can express their level of agreement on a 7-point Likert scale ranging from 'strongly disagree' (1) to 'strongly agree' (7). Items 1 and 9 need to be scored reversely. Scores are averaged to create a composite score and higher scores represent greater psychosocial distress. |
Baseline, 12 months
|
Yhteistyökumppanit ja tutkijat
Sponsori
Sponsori
Tutkijat
Tutkijat
- Päätutkija: Kyla Lara-Breitinger, M.D., Mayo Clinic
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Opiskelun aloitus
Ensisijainen valmistuminen (Arvioitu)
Ensisijainen valmistuminen
Opintojen valmistuminen (Arvioitu)
Opintojen valmistuminen
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Ensimmäinen Lähetetty
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin päivitys julkaistu
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
Muut tutkimustunnusnumerot
- 26-008806
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .